Federal contract award
75A50124C00032
BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST SHARING |
| Obligations | $69.9M |
| Current contract value | $69.9M |
| Potential contract value / ceiling | $122.8M |
| Start date | Aug 9, 2024 |
| Current end date | Nov 30, 2029 |
| Potential end date | Nov 30, 2029 |
| Latest award activity | Sep 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2026 | P00004 | $8.9M | 1) EXERCISE AND FUND OPTION 2 - CLIN 0003 IN THE AMOUNT OF $$8,897,961.93. 2) UPDATE SECTION J - ATTACHMENT 1 - STATEMENT OF WORK. |
| Jul 27, 2026 | P00003 | $27.6M | 1) INCORPORATE THE CLAUSES MANDATED BY EXECUTIVE ORDER EO 14398 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS INTO THE CONTRACT. 2) EXERCISE AND FUND OPTION 11 - CLIN 0012 IN THE AMOUNT OF $27,600,000.00. 3) UPDATE SECTION J - ATTACHMENT 1 |
| Mar 3, 2026 | P00002 | $12.4M | BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY |
| Aug 9, 2024 | P00001 | $0 | BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY |
| Aug 8, 2024 | 0 | $21.0M | BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY |
Estimated positioning window
Nov 30, 2028 – May 30, 2029
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2029-11-30 (1125 days from calculation)
- +5 points
- 22 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-09-04
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.